Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors.

MLA

Leegwater, Emiel, et al. “Hypokalaemia in Patients Treated with Intravenous Flucloxacillin: Incidence and Risk Factors.” British Journal of Clinical Pharmacology, vol. 88, no. 6, June 2022, pp. 2938–45. EBSCOhost, https://doi.org/10.1111/bcp.15236.

APA

Leegwater, E., Westgeest, A. C., Schippers, E. F., Wilms, E. B., van Nieuwkoop, C., & Visser, L. E. (2022). Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors. British Journal of Clinical Pharmacology, 88(6), 2938–2945. https://doi.org/10.1111/bcp.15236

Chicago

Leegwater, Emiel, Annette C Westgeest, Emile F Schippers, Erik B Wilms, Cees van Nieuwkoop, and Loes E Visser. 2022. “Hypokalaemia in Patients Treated with Intravenous Flucloxacillin: Incidence and Risk Factors.” British Journal of Clinical Pharmacology 88 (6): 2938–45. doi:10.1111/bcp.15236.